PR1 leukemia peptide vaccine Uses, Dosage, Side Effects and more
PR1 leukemia peptide vaccine is under investigation in clinical trial NCT00513578 (Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome).
| Trade Name | PR1 leukemia peptide vaccine |
| Generic | PR1 leukemia peptide vaccine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
